Silicon Valley Capital Partners’s Elevance Health ELV Stock Holding History

Silicon Valley Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-91	Closed	-$39.5K	–	314
2025 Q1	$39.5K	Hold	91	–	–	0.01%	147
2024 Q4	$33.6K	Hold	91	–	–	﹤0.01%	163
2024 Q3	$47.2K	Buy	91 +1	+1%	+$534	0.01%	135
2024 Q2	$49K	Hold	90	–	–	0.01%	129
2024 Q1	$46.8K	Hold	90	–	–	0.01%	125
2023 Q4	$42.4K	Hold	90	–	–	0.01%	110
2023 Q3	$39K	Buy	90 +1	+1%	+$454	0.01%	106
2023 Q2	$39.7K	Buy	+89	New	+$41.1K	0.01%	107

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Silicon Valley Capital Partners's ELV Position: Q2 2025 in Review

Silicon Valley Capital Partners sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 91 shares — an estimated $39.5K sold.

Silicon Valley Capital Partners first reported a position in ELV in Q2 2023 and held it in 8 quarters. The position peaked at $49K in Q2 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Silicon Valley Capital Partners reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Silicon Valley Capital Partners sold 91 Elevance Health shares in Q2 2025, an estimated $39.5K.
Silicon Valley Capital Partners first reported a position in Elevance Health in Q2 2023 and held it in 8 quarters.
Silicon Valley Capital Partners's Elevance Health position peaked at $49K in Q2 2024.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Silicon Valley Capital Partners's 13F filing for Q2 2025, filed 11 Sep 2025.